Translational biomedical research promises to turn new medical discoveries into tangible cures and Saint Joseph's Research Institute (SJRI) is at the forefront of this new paradigm.
Groundbreaking research already is underway using tissue engineering, cell therapy and gene therapy with the potential to dramatically improve patient outcomes. In the future these discoveries will move rapidly from the laboratory to clinical trials, providing “bench to bedside” care so that patients can receive the very best protocols, devices and pharmaceuticals for treatment – fast.
Saint Joseph's is committed to being a leader in the field of translational research, conducting pre-clinical and clinical research and trials, education and data outcomes analysis. Treatments will be developed sooner, in a context where they can be used better. Saint Joseph's also will play an important role in training physicians on how to use emerging treatments and devices. Conversely, collaboration among scientists and physicians will enable researchers to identify patient needs at the bedside and work on solutions in the lab to meet them.
Research currently underway at SJRI includes:
Angiogenesis – focuses on gene and protein therapies aimed at increasing blood vessel growth in patients whose hearts or limbs lack an adequate blood supply. In clinical trials, patients have grown new blood vessels in both hearts and legs, dramatically reversing the effects of heart attacks and diabetes. In the future, angiogenesis could improve the quality of life for patients with heart disease by eliminating the need for many surgeries.
Coronary intervention studies – examines treatments for narrowed arteries including medical therapies, radiation and the use of drug-eluting stents. SJRI was extensively involved in the initial research using drug-eluting stents, and as a result the devices were available at Saint Joseph's long before other hospitals could offer them.
Cardiothoracic and vascular tissue engineering – utilizes cell line therapy to grow, repair or replace damaged heart muscles and valves. Translational research in the field of tissue engineering is another way SJRI promises to provide heart patients better outcomes with less cost and quicker recovery.
For more information about SJRI, call 678-843-6050.
Saint Joseph's Translational Research Institute
Known as a leader in the treatment of cardiac and vascular diseases, orthopaedics, cancer, gastroenterology, and diabetes. Saint Joseph's Hospital of Atlanta is committed to translational research through activities in the Saint Joseph's Translational Research Institute (SJTRI).
SJTRI has gathered scientists, industry partners, recognized physicians, and a collaborative network of national leaders in the evolving arena of translational research. Integrating top research scientists, sophisticated research facilities, education and training, SJTRI is engaged in bold and exciting programs designed to assist in the investigation of cutting edge treatments with potential benefits to patients and the community.
